Literature DB >> 7892014

The N-methyl-D-aspartate receptor antagonist dextromethorphan selectively reduces temporal summation of second pain in man.

Donald D Price1, Jianren Mao, Hanan Frenk, David J Mayer.   

Abstract

Oral doses of dextromethorphan (DM), a common cough suppressant and N-methyl-D-aspartate (NMDA) receptor antagonist, and their vehicle control were given on a double-blind basis to normal volunteer human subjects who rated intensities of first and second pain in response to repeated painful electric shocks and repeated 52 degrees C heat pulses. Doses of 30 and 45 mg, but not 15 mg, were effective in attenuating temporal summation of second pain, a psychophysical correlate of temporal summation of C afferent-mediated responses of dorsal horn nociceptive neurons, termed 'wind-up'. By contrast, neither first nor second pain evoked by the first stimulus in a train of stimuli were affected by any of these doses of DM. These results further confirm temporal summation of second pain as a psychophysical correlate of wind-up by providing evidence that DM selectively reduces temporal summation of second pain, as has been shown for wind-up.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7892014     DOI: 10.1016/0304-3959(94)90069-8

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  50 in total

1.  Assessment of the effect of dextromethorphan and ketamine on the acute nociceptive threshold and wind-up of the second pain response in healthy male volunteers.

Authors:  A M Hughes; J Rhodes; G Fisher; M Sellers; J W Growcott
Journal:  Br J Clin Pharmacol       Date:  2002-06       Impact factor: 4.335

2.  Brain activity related to temporal summation of C-fiber evoked pain.

Authors:  Roland Staud; Jason G Craggs; Michael E Robinson; William M Perlstein; Donald D Price
Journal:  Pain       Date:  2006-12-06       Impact factor: 6.961

3.  The dynamics of pain: evidence for simultaneous site-specific habituation and site-nonspecific sensitization in thermal pain.

Authors:  Marieke Jepma; Matt Jones; Tor D Wager
Journal:  J Pain       Date:  2014-04-24       Impact factor: 5.820

Review 4.  Combined opioid-NMDA antagonist therapies. What advantages do they offer for the control of pain syndromes?

Authors:  Z Wiesenfeld-Hallin
Journal:  Drugs       Date:  1998-01       Impact factor: 9.546

Review 5.  Preemptive analgesia: the prevention of neurogenous orofacial pain.

Authors:  P A Foreman
Journal:  Anesth Prog       Date:  1995

6.  Methodological Considerations for the Temporal Summation of Second Pain.

Authors:  Nathanial R Eckert; Charles J Vierck; Corey B Simon; Sachell Calderon; Yenisel Cruz-Almeida; Roland Staud; Roger B Fillingim; Joseph L Riley
Journal:  J Pain       Date:  2017-08-09       Impact factor: 5.820

7.  Altered quantitative sensory testing outcome in subjects with opioid therapy.

Authors:  Lucy Chen; Charlene Malarick; Lindsey Seefeld; Shuxing Wang; Mary Houghton; Jianren Mao
Journal:  Pain       Date:  2009-02-23       Impact factor: 6.961

Review 8.  Predictors of clinical pain intensity in patients with fibromyalgia syndrome.

Authors:  Roland Staud
Journal:  Curr Rheumatol Rep       Date:  2004-08       Impact factor: 4.592

9.  Temporal summation of pain characterizes women but not men with temporomandibular disorders.

Authors:  Eleni Sarlani; Pauline H Garrett; Edward G Grace; Joel D Greenspan
Journal:  J Orofac Pain       Date:  2007

10.  Preoperative oral dextromethorphan does not reduce pain or morphine consumption after open cholecystectomy.

Authors:  Hossein Mahmoodzadeh; Ali Movafegh; Noshin Mosavi Beigi
Journal:  Saudi J Anaesth       Date:  2009-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.